Clinical Trial Update: A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection [Phase 2]

View source ↗

Summary

Phase 2 study in Japan evaluating safety and antiviral activity for chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED